Report on the Use of Proceeds
170
Use Β:
1. Arcela allocated total funds of €4.850.000,00 on 26.07.2022, 27.07.2022, 22.08.2022, 20.10.2022 and
19.12.2022, as an advance payment in the context of a future share capital increase, to its wholly
owned subsidiary Alkanor S.M.S.A. for the financing of the "Minion" project (as presented in section
3.5.1 of the Prospectus). The General Meetings of the sole shareholder of Alkanor S.M.S.A. dated
23.12.2022 and 30.12.2022 resolved on the increase of the share capital by €3,900,000.00 and
€1,100,000.00, respectively, i.e. a total amount of €5,000,000.00, of which €4,850,000.00 derived from
the proceeds raised. The total cost of the project implemented during the period 05.07.2022 to
31.12.2022 amounted to €5,099,765.80. As of 31.12.2022, of the total amount of the above proceeds,
an amount of €4,664,183.61 had been definitively allocated to the project, while an amount of
€185,816.39 remained in a deposit account of Alkanor S.M.S.A. for its final allocation.
2. Arcela allocated total funds of €8,110,000.00 on 22.08.2022, 03.11.2022 and 16.11.2022, through a
share capital increase, to its wholly owned subsidiary Magromell Limited, and subsequently
Magromell, as an advance payment in the context of a future share capital increase, to its wholly
owned subsidiary IQ Athens M.A.E. to finance the "Iera Odos" project (as presented in section 3.5.1 of
the Prospectus). The EGM of the sole shareholder of IQ Athens S.M.S.A. dated 28.12.2022 resolved on
the share capital increase for a total amount of €10,355,000.00, of which €8,110,000.00 derived from
the proceeds raised as described above. The total cost of the project implemented during the period
05.07.2022 to 31.12.2022 amounted to €8,681,327.68. As of 31.12.2022 IQ Athens had fully allocated
the total amount of the above raised proceeds.
3. Arcela allocated funds of €2,945,000.00 on 21.09.2022, through a share capital increase, to its wholly
owned subsidiary Alabana Limited, of which €2,940,000 drived from the proceeds raised. On
29.9.2022, Alabana proceeded, in accordance with the terms of the share purchase and sale
agreements dated 28.09.2021, with the acquisition of an 18.33% stake in 3V S.A., for a total
consideration of €2,939,959.85 plus expenses of €1,068.00. Following the above acquisition, Alabana's
final stake in 3V amounted to 55.00%. The above transaction is presented in section 3.5.1 of the
Prospectus.
4. Arcela allocated total funds of €7,865,000.00 on 18.10.2022, 08.11.2022, 10.11.2022, 14.11.2022 and
16.12.2022, as advance payment in the context of a future share capital increase, to its wholly owned
subsidiary Filma S.M.S.A. for the financing of the "FIX" project (as presented in section 3.5.1 of the
Prospectus). The EGM of the sole shareholder of Filma S.M.S.A. dated 23.12.2022 rresolved on the
increase of the share capital for a total amount of €10,630,000.00, of which €7,865,000.00 derived
from the raised proceeds. The total cost of the project implemented during the period 05.07.2022 to
31.12.2022 amounted to €9,530,009.46. As of 31.12.2022, Filma had fully allocated the total amount
of the above-mentioned raised proceeds.
5. Arcela allocated total funds of €1,599,000.00 on 18.10.2022, through a share capital increase, to Cante
Holdings Limited (in proportion to its shareholding, i.e., 65%). Cante subsequently allocated the total
funds of the aforementioned share capital increase to Piraeus Tower S.A., in which it holds a 70%
stake, for the financing of the "Piraeus Tower" project (as presented in section 3.5.1 of the Prospectus).
The AGM of the shareholders of Piraeus Tower S.A. dated 08.09.2022 resolved on the share capital
capital of Piraeus Tower S.A. for a total amount of €3,515,000.00, of which €1,599,000.00 derived from
the raised proceeds. The total cost of the project implemented during the period 05.07.2022 to
31.12.2022 amounted to €13,112,812.85. As of 31.12.2022 Piraeus Tower had fully allocated the total
amount of the above raised proceeds.